GigCapital5 (GIA) Appoints Sharmila Makhija to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Dr. Sharmila Makhija Joins GigCapital5 Board of Directors
January 5, 2022 4:15 PM ESTPALO ALTO, Calif.--(BUSINESS WIRE)-- GigCapital5, Inc. (NYSE: GIA, GIA.U, GIA.WS) (the Company or GigCapital5) today announced that Dr. Sharmila Makhija, MD, MBA, an international expert on gynecologic cancer, has joined the Companys Board of Directors.
In addition, Dr. Makhija will serve as Healthcare Advisor to GigCapital5s affiliate and serial SPAC issuer GigCapital Global (GigCapital). In her role as Healthcare Advisor to GigCapital, Dr. Makhija provides her medical and business expertise across its Private-to-Public Equity (PPE) initiatives, which includes six public SPACs, four of which have closed transactions Kaleyra (NYSE: KLR),... More



